A307280 Stock Overview
Wonbiogen Co., Ltd. develops and sells medical equipment in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Wonbiogen Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,787.00 |
| 52 Week High | ₩2,635.00 |
| 52 Week Low | ₩1,473.00 |
| Beta | 0.75 |
| 1 Month Change | 1.53% |
| 3 Month Change | 7.13% |
| 1 Year Change | -6.64% |
| 3 Year Change | -33.57% |
| 5 Year Change | n/a |
| Change since IPO | -55.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| A307280 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0.1% | 3.5% | -2.4% |
| 1Y | -6.6% | 22.2% | 1.9% |
Return vs Industry: A307280 underperformed the KR Medical Equipment industry which returned 22.2% over the past year.
Return vs Market: A307280 underperformed the KR Market which returned 1.9% over the past year.
Price Volatility
| A307280 volatility | |
|---|---|
| A307280 Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A307280 has not had significant price volatility in the past 3 months.
Volatility Over Time: A307280's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 59 | Kim Won | www.wonbiogen.co.kr |
Wonbiogen Co., Ltd. develops and sells medical equipment in South Korea. The company offers medical supplies, medical appliances, and OEM products. It also provides dressing materials fit for wet environment.
Wonbiogen Co., Ltd. Fundamentals Summary
| A307280 fundamental statistics | |
|---|---|
| Market cap | ₩63.39b |
| Earnings (TTM) | ₩5.50b |
| Revenue (TTM) | ₩29.61b |
11.5x
P/E Ratio2.1x
P/S RatioIs A307280 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A307280 income statement (TTM) | |
|---|---|
| Revenue | ₩29.61b |
| Cost of Revenue | ₩15.47b |
| Gross Profit | ₩14.15b |
| Other Expenses | ₩8.65b |
| Earnings | ₩5.50b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 154.97 |
| Gross Margin | 47.77% |
| Net Profit Margin | 18.56% |
| Debt/Equity Ratio | 20.8% |
How did A307280 perform over the long term?
See historical performance and comparison